For a broader selection, explore the Vitamin B12 Injections Collection at Mountainside Medical
Drug and Alcohol Dependence, 156, 113
Second, research into modified MOTS-c analogs, peptides engineered to be more stable in plasma or to have enhanced receptor binding, is already producing candidates with longer half-lives and potentially greater potency at lower doses [3]
The typical patient profile for whom MIC B12 represents good value: confirmed or suspected B12 deficiency, seeking energy improvement and modest weight-loss support, not ready for or not qualifying for GLP-1 therapy, willing to self-inject weekly
So for the most common long-term situation, an absorption problem, maintenance means one injection every two to three months rather than anything weekly or monthly